
    
      Study Population Patients with non-valvular atrial fibrillation and previous AF-related
      embolic events Purpose To assess the feasibility and safety of percutaneous LAA closure as
      secondary prevention for patients with non-valvular atrial fibrillation (NVAF) and previous
      atrial fibrillation (AF) related embolic events (including ischemic stroke, transient
      ischemic attack (TIA), and systemic embolism).
    
  